Sedor John A

PresidentBENTLEY PHARMACEUTICALS INC (BNT) · full profile →Form 4 · filed Jul 24, 2008
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
2 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 22, 2008Disposed to issuer(D)4K$14.82$59K0
Jul 22, 2008Disposed to issuer(D)7K$14.82$108K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 22, 2008Disposed to issuer(D)100K0
Jul 22, 2008Disposed to issuer(D)50K0
Jul 22, 2008Disposed to issuer(D)47K0
Jul 22, 2008Disposed to issuer(D)15K0
Jul 22, 2008Disposed to issuer(D)107K0
Jul 22, 2008Disposed to issuer(D)25K0
Jul 22, 2008Disposed to issuer(D)50K0
Jul 22, 2008Disposed to issuer(D)47K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-08-043642) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.